Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis E Wunsch, J Trottier, M Milkiewicz, J Raszeja‐Wyszomirska, ... Hepatology 60 (3), 931-940, 2014 | 126 | 2014 |
Expression of hepatic fibroblast growth factor 19 is enhanced in primary biliary cirrhosis and correlates with severity of the disease E Wunsch, M Milkiewicz, U Wasik, J Trottier, A Kempińska-Podhorodecka, ... Scientific reports 5 (1), 13462, 2015 | 103 | 2015 |
Enhanced liver fibrosis test predicts transplant‐free survival in primary sclerosing cholangitis, a multi‐centre study EMG De Vries, M Färkkilä, P Milkiewicz, JR Hov, B Eksteen, D Thorburn, ... Liver International 37 (10), 1554-1561, 2017 | 81 | 2017 |
Serum autotaxin is a marker of the severity of liver injury and overall survival in patients with cholestatic liver diseases E Wunsch, M Krawczyk, M Milkiewicz, J Trottier, O Barbier, MF Neurath, ... Scientific reports 6 (1), 30847, 2016 | 58 | 2016 |
Minimal hepatic encephalopathy does not impair health‐related quality of life in patients with cirrhosis: a prospective study E Wunsch, B Szymanik, M Post, W Marlicz, M Mydłowska, P Milkiewicz Liver International 31 (7), 980-984, 2011 | 54 | 2011 |
Assessment of health related quality of life in polish patients with primary biliary cirrhosis J Raszeja-Wyszomirska, E Wunsch, M Krawczyk, EI Rigopoulou, ... Clinics and research in hepatology and gastroenterology 40 (4), 471-479, 2016 | 52 | 2016 |
Esophageal duplication cysts: endosonographic findings in asymptomatic patients A Wiechowska-Kozłowska, E Wunsch, M Majewski, P Milkiewicz World journal of gastroenterology: WJG 18 (11), 1270, 2012 | 47 | 2012 |
Autoimmune hepatitis exerts a profound, negative effect on health‐related quality of life: a prospective, single‐centre study MK Janik, E Wunsch, J Raszeja‐Wyszomirska, M Moskwa, B Kruk, ... Liver International 39 (1), 215-221, 2019 | 46 | 2019 |
Effect of S-adenosyl-L-methionine on liver biochemistry and quality of life in patients with primary biliary cholangitis treated with ursodeoxycholic acid. A prospective, open … E Wunsch, J Raszeja-Wyszomirska, O Barbier, M Milkiewicz, M Krawczyk, ... J Gastrointestin Liver Dis 27 (3), 273-279, 2018 | 46 | 2018 |
The effect of short term treatment with probiotic VSL# 3 on various clinical and biochemical parameters in patients with liver cirrhosis W Marlicz, E Wunsch, M Mydlowska, M Milkiewicz, K Serwin, M Mularczyk, ... J Physiol Pharmacol 67 (6), 867-877, 2016 | 44 | 2016 |
Vitamin D receptor polymorphisms predispose to primary biliary cirrhosis and severity of the disease in polish population A Kempińska-Podhorecka, E Wunsch, T Jarowicz, ... Gastroenterology Research and Practice 2012 (1), 408723, 2012 | 43 | 2012 |
Normalization of the psychometric hepatic encephalopathy score in Polish population. A prospective, quantified electroencephalography study E Wunsch, D Koziarska, K Kotarska, P Nowacki, P Milkiewicz Liver international 33 (9), 1332-1340, 2013 | 41 | 2013 |
Factors affecting health‐related quality of life and physical activity after liver transplantation for autoimmune and nonautoimmune liver diseases: a prospective, single centre … K Kotarska, E Wunsch, A Kempińska-Podhorodecka, ... Journal of immunology research 2014 (1), 738297, 2014 | 40 | 2014 |
Mini-Mental State Examination in patients with hepatic encephalopathy and liver cirrhosis: a prospective, quantified electroencephalography study D Koziarska, E Wunsch, M Milkiewicz, M Wójcicki, P Nowacki, ... BMC gastroenterology 13, 1-7, 2013 | 39 | 2013 |
Impaired hepatic adaptation to chronic cholestasis induced by primary sclerosing cholangitis M Milkiewicz, M Klak, A Kempinska-Podhorodecka, ... Scientific Reports 6 (1), 39573, 2016 | 36 | 2016 |
Prospective evaluation of PBC‐specific health‐related quality of life questionnaires in patients with primary sclerosing cholangitis J Raszeja‐Wyszomirska, E Wunsch, M Krawczyk, EI Rigopoulou, ... Liver International 35 (6), 1764-1771, 2015 | 36 | 2015 |
Anti‐glycoprotein 2 (anti‐GP2) IgA and anti‐neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3‐ANCA): antibodies to predict severe disease, poor survival and … E Wunsch, GL Norman, M Milkiewicz, M Krawczyk, C Bentow, Z Shums, ... Alimentary Pharmacology & Therapeutics 53 (2), 302-313, 2021 | 35 | 2021 |
Plasmapheresis exerts a long‐lasting antipruritic effect in severe cholestatic itch M Krawczyk, R Liebe, M Wasilewicz, E Wunsch, J Raszeja‐Wyszomirska, ... Liver International 37 (5), 743-747, 2017 | 35 | 2017 |
Impact on follow‐up strategies in patients with primary sclerosing cholangitis A Bergquist, TJ Weismüller, C Levy, C Rupp, D Joshi, JS Nayagam, ... Liver international 43 (1), 127-138, 2023 | 32 | 2023 |
The prevalence of anti-hexokinase-1 and anti-kelch-like 12 peptide antibodies in patients with primary biliary cholangitis is similar in Europe and North America: a large … GL Norman, A Reig, O Viñas, M Mahler, E Wunsch, P Milkiewicz, ... Frontiers in immunology 10, 662, 2019 | 29 | 2019 |